The relationship between serum lipoprotein (a) levels and ischemic stroke risk: A cohort study in the Chinese population

Inflammation

Volumn 37, Issue 3, 2014, Pages 686-693

  Li, Shao Yi ^a   Gao, Yun ^a   Ma, Wei Ning ^a   Wang, Hua Chao ^a   Zhou, Gang ^a   Guo, Wen Chang ^a   Liu, Yun Hui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

acute ischemic stroke; biomarker; Chinese; lipoprotein (a); risk; serum

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; LIPOPROTEIN A; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHINESE; COHORT ANALYSIS; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATHOGENESIS; POPULATION; RISK FACTOR; SEX DIFFERENCE; BLOOD; CHINA; MIDDLE AGED; STROKE;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CHINA; COHORT STUDIES; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 84902533514     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9785-x     Document Type: Article

References (46)

1. Vucković, B.A., M.J. Djerić, T.A. Ilić, V.B. Canak, S.L.J. Kojić-Damjanov, M.G. Zarkov, and V.S. Cabarkapa. 2010. Fibrinolytic parameters, lipid status and lipoprotein(a) in ischemic stroke patients. Srpski Arhiv za Celokupno Lekarstvo 138(1): 12-17.
2. Tu, W.J., X. Dong, S.J. Zhao, D.G. Yang, and H. Chen. 2013. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. Journal of Neuroendocrinology 25: 771-778.
3. Unal, E., S. Mungan, S. Bilen, Y. Karadag, N. Oztekin, F. Bakir, and F. Ak. 2013. The effects of lipoprotein(a) and homocysteine on prognosis and risk factors in acute ischemic stroke. International Journal of Neuroscience 123: 532-536.
4. Uno, M., K.T. Kitazato, K. Nishi, H. Itabe, and S. Nagahiro. 2003. Raised plasma oxidized LDL in acute cerebral infarction. Journal of Neurology, Neurosurgery and Psychiatry 74: 312-316. (Pubitemid 36259353)
5. Nordestgaard, B.G., M.J. Chapman, K. Ray, J. Borén, F. Andreotti, G.F. Watts, H. Ginsberg, P. Amarenco, A. Catapano, O.S. Descamps, E. Fisher, P.T. Kovanen, J.A. Kuivenhoven, P. Lesnik, L. Masana, Z. Reiner, M.R. Taskinen, L. Tokgözoglu, and A. Tybjærg-Hansen. 2010. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. European Heart Journal 31: 2844-2853.
6. Morishita, R., J. Ishii, Y. Kusumi, S. Yamada, N. Komai, M. Ohishi, M. Nomura, H. Hishida, M. Niihashi, and M. Mitsumata. 2009. Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vascular wall. Journal of Atherosclerosis and Thrombosis 16: 410-418.
7. Rosas, S., M. Joffe, M. Wolfe, K. Brayman, and D.J. Rader. 2008. Effects of renal replacement therapy on plasma lipoprotein(a) levels. American Journal of Nephrology 28: 361-365. (Pubitemid 351501600)
8. Bruckert, E., P. Davidoff, A. Grimaldi, J. Truffert, P. Giral, R. Doumith, F. Thervet, and J.L. De Gennes. 1990. Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA 263: 35-36. (Pubitemid 20032188)
9. Wright, L.C., D.R. Sullivan, M. Muller, M. Dyne, M.H. Tattersall, and C.E. Mountford. 1989. Elevated apolipoprotein(a) levels in cancer patients. International Journal of Cancer 43: 241-244. (Pubitemid 19062417)
10. Engler, H., and W.F. Riesen. 1993. Effect of thyroid function on concentrations of lipoprotein(a). Clinical Chemistry 39: 2466-2469. (Pubitemid 24008230)
11. Milionis, H.J., V. Mittari, G. Exarchakos, R. Kalaitzidis, A.T. Skevas, and M.S. Elisaf. 2003. Lipoprotein (a) and acute-phase response in patients with vestibular neuronitis. European Journal of Clinical Investigation 33: 1045-1050. (Pubitemid 38019138)
12. Bernick, C., L. Kuller, C. Dulberg, et al. 2001. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 57: 1222-1229. (Pubitemid 32947380)
13. Safarova, M.S., M.V. Ezhov, O.I. Afanasieva, Y.G. Matchin, R.V. Atanesyan, I.Y. Adamova, E.A. Utkina, G.A. Konovalov, and S.N. Pokrovsky. 2013. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography. Atherosclerosis Supplements 14: 93-99.
14. Berglund, L., and R. Ramakrishnan. 2004. Lipoprotein(a): an elusive cardiovascular risk factor. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 2219-2226. (Pubitemid 39658021)
15. Smolders, B., R. Lemmens, and V. Thijs. 2007. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke 38: 1959-1966. (Pubitemid 46847277)
16. Boden-Albala, B., D.E. Kargman, I.F. Lin, M.C. Paik, R.L. Sacco, and L. Berglund. 2010. Increased stroke risk and lipoprotein (a) in a multiethnic community: the Northern Manhattan Stroke Study. Cerebrovascular Diseases 30: 237-243.
17. Ariyo, A.A., C. Thach, and R. Tracy. 2003. Cardiovascular Health Study Investigators. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. New England Journal of Medicine 349: 2108-2115.
18. Milionis, H.J., A.F. Winder, and D.P. Mikhailidis. 2000. Lipoprotein (a) and stroke. Journal of Clinical Pathology 53: 487-496. (Pubitemid 30432104)
19. Ohira, T., P. Schreiner, J. Morrisett, L. Chambless, W. Rosamond, and A. Folsom. 2006. Lipoprotein(a) and incident ischemic stroke: the Atherosclerotic Risk in Communities (ARIC) study. Stroke 37: 1407-1412. (Pubitemid 44305717)
20. Danesh, J., R. Collins, and R. Peto. 2000. Lipoprotein (a) and coronary heart disease. Meta analysis of prospective studies. Circulation 102: 1082-1085.
21. Alfthan, G., J. Pekkanen, M. Jauhiainen, J. Pitkäniemi, M. Karvonen, J. Tuomilehto, J.T. Salonen, and C. Ehnholm. 1994. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106: 9-19. (Pubitemid 24103795)
22. Ridker, P.M., M.J. Stampfer, and C.H. Hennekens. 1995. Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 273: 1269-1273.
23. Hatano, S. 1976. Experience from a multicentre stroke register: a preliminary report. Bulletin of the World Health Organization 54: 541-553. (Pubitemid 8114220)
24. Katan, M., F. Fluri, and N.G. Morgenthaler. 2009. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Annals of Neurology 66: 799-808.
25. Brott, T., J.R. Marler, C.P. Olinger, et al. 1989. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 20: 871-875. (Pubitemid 19188241)
26. Adams Jr., H.P., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L. Gordon, and E.E. Marsh 3rd. 1993. Classification of subtype of acute ischemic stroke: definitions for use in amulticenter clinical trial. TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41. (Pubitemid 23014379)
27. Kamstrup, P.R., A. Tybjaerg-Hansen, R. Steffensen, and B.G. Nordestgaard. 2009. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301: 2331-2339.
28. Matthews, K.A., M.F. Sowers, C.A. Derby, E. Stein, H. Miracle-McMahill, S.L. Crawford, and R.C. Pasternak. 2005. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). American Heart Journal 149: 1066-1073. (Pubitemid 40848152)
29. Tu, W.J., S.J. Zhao, T.G. Liu, D.G. Yang, and H. Chen. 2013. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurological Research 35: 912-921.
30. Ridker, P.M., J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens. 1998. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731-733. (Pubitemid 28391836)
31. Kistorp, C., I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt. 2005. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293: 1609-1616. (Pubitemid 40471791)
32. Wiberg, B., J. Sundstrom, J. Arnlov, A. Terent, B. Vessby, B. Zethelius, and L. Lind. 2006. Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up. Stroke 37: 2898-2903. (Pubitemid 44900808)
33. Dhamija, R.K., P. Gaba, S. Arora, A. Kaintura, M. Kumar, and J. Bhattacharjee. 2009. Homocysteine and lipoprotein (a) correlation in ischemic stroke patients. Journal of Neurological Sciences 281: 64-68.
34. Hachinski, V., C. Graffagnino, M. Beaudry, et al. 1996. Lipids and stroke paradox resolved. Archives of Neurology 53: 303-308.
35. van Kooten, F., J. van Krimpen, D.W. Dippel, N. Hoogerbrugge, and P.J. Koudstaal. 1996. Lipoprotein(a) in patients with acute cerebral ischemia. Stroke 27: 1231-1235.
36. Ariyo, A.A., C. Thach, and R. Tracy. 2003. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. New England Journal of Medicine 349: 2108-2115. (Pubitemid 37464535)
37. Hajjar, K.A., and D. Gavish. 1989. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339: 303-305. (Pubitemid 19130696)
38. Boerwinkle, E., C.C. Leffert, J. Lin, C. Lackner, G. Chiesa, and H.H. Hobbs. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. Journal of Clinical Investigation 90: 52-60.
39. Tascilar, N., S. Ekem, and E. Aciman. 2009. Hyperhomocysteinemia as an independent risk factor for cardioembolic stroke in Turkish population. Tohoku Journal of Experimental Medicine 218: 293-300.
40. Rath, M., A. Niendorf, T. Reblin, M. Dietel, H.J. Krebber, and U. Beisiegel. 1989. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9: 579-592. (Pubitemid 19236892)
41. Kim, B.S., H.S. Jung, O.Y. Bang, C.S. Chung, K.H. Lee, and G.M. Kim. 2010. Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke. Atherosclerosis 212: 682-688.
42. Von Depka, M., U. Nowka-Göttl, R. Eisert, C. Dieterich, M. Barthels, I. Scharrer, A. Ganser, and S. Ehrenforth. 2000. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 96: 3364-3368.
43. Barre, D.E., O. Griscti, K.A. Mizier-Barre, and K. Hafez. 2005. Flaxseed oil and lipoprotein (a) significantly increase bleeding time in type 2 diabetes patients in Cape Breton, Nova Scotia. Canada. Journal of Oleo Science 54: 347-354.
44. Dangas, G., R. Mehran, P.C. Harpel, et al. 1998. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. Journal of the American College of Cardiology 32: 2035-2042. (Pubitemid 29010473)
45. Ohtahara, A., I. Hisatome, Y. Yamamoto, M. Furuse, K. Sonoyama, Y. Furuse, et al. 2001. The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and [alpha] 1-blockers. Journal of Hypertension 19: 575-582. (Pubitemid 32280949)
46. Harpel PC, Chang VT, Borth W. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. PNAS 1992:10193-10197.